INTRODUCTION 73
SYNGAP1 codes for synaptic Ras GTPase activating protein 1 (SYNGAP1), a Ras-74 GAP critical for the formation of postsynaptic densities (PSDs) and the experience-dependent 75 AMPA receptor (AMPAR) insertion that underlies synaptic plasticity (1-5). Mutations in 76 SYNGAP1 are prevalent in patients with schizophrenia, intellectual disability (ID), and autism 77 spectrum disorder (6-8). Loss-of-function SYNGAP1 mutations result in haploinsufficiency and 78 cause mental retardation type 5 (MRD5, OMIM#612621), a severe distinct generalized 79 developmental and epileptic encephalopathy with ID, ataxia, severe behavioral problems, and 80 a risk for autism (6) (7) (8) (9) (10) (11) (12) . 81
The majority of patients with MRD5 have refractory epilepsy (12). Poor quality sleep is 82 highly prevalent in patients with neurodevelopmental disorders (NDDs) and epilepsy (13, 14) . 83
The relationship between epilepsy and sleep is a major focus of ongoing clinical and pre-84 clinical research (13) (14) (15) . For example, Rett syndrome (RTT) is an NDD with epilepsy and 85 sleep dysfunction (16, 17) . Research in both pre-clinical models of RTT and patients with RTT 86 has identified translatable quantitative EEG (qEEG) biomarkers (17, 18) . There is an urgent 87 need to develop robust biomarkers for NDDs, as bench-to-bedside therapeutic strategies are 88 severely hindered without validated quantitative outcome measures. 89
Patients with MRD5 predominantly present with myoclonic, absence, or tonic-clonic 90 seizures (8,12). Children with epileptic encephalopathies have a slow developmental 91 regression that is primarily due to seizures, interictal spikes (IISs), or cortical dysrhythmia 92 identified on EEG (19, 20) . Case reports indicate that adult patients demonstrate gradual 93 decline in cognitive abilities (21) . Perampanel (PMP), a recently FDA approved AMPAR 94 antagonist has shown significant promise for multiple seizure types in idiopathic generalized 95 epilepsies including absence (22) . Its use in infants with epilepsy is in clinical trial (23). 96
However, the role of AMPAR antagonists such as PMP in SYNGAP1 haploinsufficiency related 97 seizures and ID is unknown. 98
Mice with Syngap1 haploinsufficiency (Syngap1 +/-) are relevant translational models 99 presenting with learning and memory deficits, abnormal dendritic spine dynamics, cortical 100 hyperexcitability, and precocious unsilencing of thalamocortical synapses during development 101 Institutes of Health. All protocols used in this study were approved by the Committee on the 114
Ethics of Animals Experiments of the Johns Hopkins University. In Syngap1 +/mice, exons 7 115 and 8 (C2 domain) were replaced with a neomycin resistance gene in the opposite direction to 116 eliminate all possible slice variants (26). All mice were single-housed at P46 (7d before 117 electrode implantation surgeries) in polycarbonate cages with food and water provided ad 118 libitum, on a 12h light-dark cycle. All efforts were made to minimize animal suffering and the 119 total number of animals used. 120 121
Surgery and 24h Video-EEG/EMG 122
All surgical procedures implemented in this study are as previously published (27). 123
Briefly, subdural EEG and suprascapular EMG electrode implantation was performed under 124 isoflurane anesthesia (4-1.5%). EEG screw electrodes utilized coordinates from bregma for 125 consistent placement (Supplemental Fig. 1 ), as previously published (18). After recovering 126 from electrode implantation surgery (7±1 day), mice were placed in a recording chamber with 127 food and water provided ad libitum. WT +/+ and Syngap1 +/mice underwent 24h vEEG/EMG 128 recording at younger (P60; WT +/+ N=4 mice and Het +/-N=6 mice) and older (P90-120; WT +/+ 129
Seizure and IIS Scoring 140
Spontaneous seizures were identified by manual review of all 24h EEGs by a scorer 141 blinded to genotype and sex. IISs were visually analyzed on raw EEG using conservative 142 parameters obtained from obvious pre-and post-ictal spikes for every 5s EEG epoch. 
Syngap1 +/mice have recurrent spontaneous seizures with multiple phenotypes 171
Continuous 24h vEEG/EMG recordings at temporally advancing ages identified 172 spontaneous seizures in 50% (n/n mice; 4/8) of Syngap1 +/mice ( Fig. 1) . At P60 all seizures 173 were myoclonic (n/n seizures; 5/5); 80% (4/5) of these seizures started in non-rapid eye 174 movement (NREM) at transitions from NREM to wake ( Fig. 1A) . Myoclonic seizures were 175 34.4±5.9s in duration with rhythmic spike-wave discharges occurring ~3-4Hz ( Fig. 1A) , similar 176 to clinical reports (12). The myoclonic seizures were distinguished by their time-locked 177 myoclonic jerks recorded on EMG with video confirmation of head, neck, and upper shoulder 178 myoclonic jerks (see Supplemental Video 1). 179
Multiple seizure phenotypes were identified in P120 +/mice, consistent with the latest 180 clinical reports (12,31). Myoclonic, generalized tonic-clonic, and electrographic seizures were seizures occurred during wake (7/11 seizures; Fig 1C3) . Electrographic (subclinical) seizures 184 were distinguished by their abnormal EEG patterns that were apparent only on EEG and not 185 associated with any behavioral change. Myoclonic seizures had a propensity to emerge during 186 NREM regardless of age. From P60 to P120, the average seizure duration significantly 187 increased from 27±0.6 to 106±22.7s (Fig. 1C1 ). This increase in seizure duration was driven 188 by the emergence of electrographic seizures at P120. Uncontrolled epilepsy is at least partially responsible for cognitive regression in children 225 with epileptic encephalopathies (19, 20) . All Syngap1 +/mice presented IISs during both sleep 226 and wake ( Fig. 4A-B ). IIS frequency significantly increased at P120 +/when compared to WT +/+ 227 mice (1-way ANOVA, F 2,20 =4.278, p=0.0284). This significant increase was driven by IISs that 228 occurred during NREM sleep, specifically during light-phase sleep ( Fig. 4C-D ). Furthermore, 229 even though the total duration of sleep increased significantly in P120 +/mice, (Fig. 3B ) the rate 230 of IIS occurrence per hour of NREM sleep was significantly greater in P120 +/mice compared 231 to WT +/+ (Fig. 4D) . 232
Emerging research utilizing intracranial recordings from epilepsy patients has 233 demonstrated that regulation of brain activity occurs on long timescales(32). Daily patterns of 234 seizure occurrence demonstrate circadian rhythmicity and clustering organization(32). In this 235 study, we report the relationship between seizure occurrence and frequency distribution of IISs 236 over 24h for all mice ( Fig. 4E -F). Grouped data of IIS frequency averaged over 24h showed an 237 escalation in IIS frequency at the beginning of the light phase, and was associated with an 238 increased incidence of seizures in P120 +/mice. Antagonizing AMPARs acutely with PMP 239 (2mg/kg I.P. at 10AM and 6PM) prevented seizures during the 24h EEG, but did not 240 significantly reduce IIS frequency (Supplemental Fig. 5 ). In summary, IIS occurrence was 241 greatest during NREM in Syngap1 +/mice. 242 243
Hyperactivity worsened with age 244
Video tracking software allows for high specificity and sensitivity when tracking mouse 245 motor activity over the 24h recordings. Total distance traveled by each mouse over a 24h 246 period was used to identify hyperactivity in Syngap1 +/mice ( Fig. 5A1-A3 ). Compared to WT +/+ 247 mice (267.92±46.8m), P120 +/mice traveled greater distances (479.75±46.1m), which was not 248 detected in the P60 +/mice (288.22±32m; Fig. 5A2-A3 ). Since P120 +/mice spent more time 249 asleep than WT +/+ mice (Fig. 3) , the distance traveled by each mouse was normalized to the 250 duration of time spent asleep. The running average of mice in each group highlighted 251 increased activity at the end of the dark phase, when the majority of nesting behavior occurs 252 (33) (Fig. 5B ). The normalized distance traveled by P120 +/mice was significantly greater than 253 WT +/+ and P60 +/mice ( Fig. 5C ). P120 +/mice spent more time asleep, but were hyperactive 254 when awake, as they travelled twice the distance compared to WT +/+ mice. These results are 255 consistent with recent reports of home cage hyperactivity in male Syngap1 +/mice (34,35). 256 257 Activity-dependent theta modulation is impaired during wake in P120 +/-258 Cross-frequency coupling occurs between theta and gamma oscillations(36,37). 259
Specifically, gamma oscillations are nested within theta oscillations(38,39) and are critical for 260 memory retrieval (40-42). To determine differences in theta and gamma power during 261 transitions from stationary-to active-wake, 10min epochs were analyzed ( Fig. 6A ). During 262 stationary-wake, high theta and low gamma power were apparent in WT +/+ mice ( Fig. 6A-B) . 263
After the transition to active-wake, WT +/+ mice had high gamma and low theta power. The 264 state-dependent (stationary-vs. active-wake) modulation of theta power was not apparent in 265 P120 +/mice ( Fig. 6B-C) . 266
In WT +/+ mice, theta and gamma spectral power demonstrated an inverse relationship 267 during wake-sleep state transitions (Supplemental Fig. 6A ). During wake, the theta-gamma 268 ratio (TGR) was low in WT +/+ mice, while during sleep the TGR was high (Supplemental Fig.  269 6A) (43,44). This relationship between theta and gamma power was lost in P120 +/mice 270 (Supplemental Fig.6A-B) . 271 272
Loss of behavioral-state homeostasis of cortical gamma 273
High cognitive load during wakefulness (45-47) is associated with increased gamma 274 power. Accordingly, in WT +/+ mice gamma power was high during wake and low during NREM 275 sleep ( Fig. 7A ). P120 +/mice did not demonstrate this behavioral state-dependent gamma 276 power modulation during Wake-NREM transitions, as gamma power remained high during 277 NREM (Fig. 7B ). PMP-treated Syngap1 +/mice showed a significant rescue of the gamma 278 dysregulation, high gamma during wake, and low gamma during NREM similar to WT +/+ mice 279 ( Fig. 7C ). In WT +/+ mice the slopes of gamma power during Wake-NREM transitions over 24h 280
were negative, as gamma power decreased during NREM. During NREM-Wake transitions, 281 the slope of gamma power was positive in WT +/+ mice as gamma power increased during wake 282 ( Fig. 7D1 ). These negative slopes of Wake-NREM transitions and the positive slopes of 283 NREM-Wake transitions were significantly different from one another in WT +/+ mice (Fig. 7D1) . 284 P120 +/mice failed to show significant differences between gamma slopes ( Fig. 7D2 ). PMP 285 significantly rescued the transition state-dependent differences between the slopes of gamma 286 power in the Syngap1 +/mice (Fig. 7D3 ). The average gamma slopes for both Wake-NREM 287 and NREM-Wake transitions were compared between groups (Supplemental Fig. 7 ). Mean 288 gamma slopes between NREM-Wake and Wake-NREM transitions in WT +/+ mice were 289 significantly different, and were lost in P120 +/mice. PMP rescued this loss in the P120 +/mice 290 (Supplemental Fig. 7 ). Further, low-dose PMP did not significantly alter cortical gamma during 291 transitions between Wake and Sleep in the WT +/+ mice that were administered PMP 292 (Supplemental Fig. 8 ). 293
Additional analyses of binned gamma power were undertaken as spectral frequency 294 analysis identified that the significant behavioral-state alterations in P120 +/gamma power 295 modulation between NREM and Wake were predominantly driven within the 35-45Hz range 296 (Supplemental Fig. 9 ). Power in the 35-45Hz bin was significantly higher during Wake 297 compared to NREM in WT +/+ mice (Supplemental Fig. 9 ), which was lost and reversed in 298 P120 +/mice (Supplemental Fig. 9 ). In summary, Syngap1 +/mice showed a loss of state-299 dependent gamma modulation. 300
During NREM the majority of brain activity is synchronous slow wave activity with low 301 gamma power (45-47). In contrast, gamma power increases during the asynchronous activity 302 of REM (45-47), hence its description as paradoxical sleep. In WT +/+ mice, NREM-REM 303 transitions underwent modulation in gamma, theta, and delta powers ( Fig. 8A & B) . A 304 significantly lower percent change in gamma power during NREM-REM transitions was 305 apparent in P120 +/mice compared to WT +/+ . This impairment in gamma power modulation 306 from NREM to REM was significantly rescued by PMP ( Fig. 8B) . 307 308
Deficits in PV+IN innervation in prefrontal cortex 309
The majority of perisomatic inhibition is mediated by parvalbumin-positive interneurons 310 (PV+INs) (45), which have a significant role in the modulation of cortical gamma 311 oscillations(48). Our novel finding of consistently high gamma power in Syngap1 +/mice 312 directed the investigation of PV+IN density distribution in the cerebral cortex, hippocampus, 313 and prefrontal cortices. PV+IN distributions did not show significant differences in overall 314 densities in the either the dorsal pallidum cortex (DP; WT +/+ vs. Het +/-: Nested t-test, 315 t 14 =0.6823, p=0.51) or the prelimbic cortex (PrL; WT +/+ vs. Het +/-: Nested t-test, t 14 =0.5755, 316 p=0.46). The quantification of total and perisomatic PV+ puncta counts identified significant 317 deficits in the DP cortex of Syngap1 +/mice ( Fig. 9A-B impermeable AMPARs) and non-PV+ neurons showed no significant differences in DP ( Fig.  321 9C-D; for antibody verification see Supplemental Fig. 10 ), or PrL. These findings indicate that 322 deficits in PV+IN innervation were region-specific within the prefrontal cortex in Syngap1 +/-323 mice. 324
These findings warranted the analysis of PV+ puncta counts in other ROIs. Unlike the 325 prefrontal cortex, no significant differences in PV+ puncta count were noted in either the barrel 326 (BCX) or motor (MCX; Fig. 10A1 ) cortices. A layer-specific investigation of BCX and MCX 327 demonstrated that PV+ puncta counts were not significantly different between layers for both 328 the total counts, and the non-PV+ somas ( Fig. 10A1-B1 ). In the hippocampus, PV+ puncta 329 counts were not significantly different in CA1 or CA3 (Fig. 10C1 ). Normalized PV+ puncta 330 counts were not significantly different between the SP, SR, or SO of WT +/+ and P120 +/mice in 331 CA1 and CA3. In summary, deficits in PV+ innervation were only observed in the DP cortex. 332 333
Increased GluA2 expression on PV+ soma in somatosensory but not motor cortex 334
A rich diversity of GABAergic neurons shape the spatiotemporal dynamics of cortical 335 circuit outputs by elegant inhibitory control mechanisms(49,50). Previous research reports that 336 compared to pyramidal neurons, PV+INs have a lower expression profile for the GluA2 337 subunit(51). PV+INs in the both L2-3 and L5-6 of the BCX showed significant upregulation of 338 GluA2 (Fig. 10A2) , which was absent in the MCX (Fig. 10B2) . The mean GluA2 fluorescence 339 intensity on PV+INs was also significantly higher in the CA3 but not in the CA1 (Fig. 10C2) . No 340 significant differences in GluA2 fluorescence intensities were noted in the non-PV+ cells in any 341 ROI investigated (Supplemental Fig. 11 ). Since all Syngap1 +/mice were epileptic, the 342 hippocampi were investigated for mossy fiber sprouting. No evidence for mossy fiber sprouting 343 was detected in this model (Supplemental Fig. 12 ). In summary, a significant region-specific Morphology of PV+INs has been identified as unipolar vs. multipolar (74) and little is 417 known about the differences in AMPA-mediated currents in these subtypes. GluA2-lacking 418
AMPARs promote anti-Hebbian long-term plasticity (75) which is critical for projection 419 interneurons that functionally connect spatially distant circuits during development. Increase of 420
GluA2-AMPARs in PV+IN soma could be one novel mechanism underlying autistic-like 421 behaviors, ID, and seizures in SYNGAP1 haploinsufficiency. Little is known of the 422 developmental and regional expression profiles of SYNGAP1 isoforms, however it is known 423 that they can exert opposing effects on synaptic strength (76). 424
To summarize, SYNGAP1 regulates synaptic plasticity, and this process is heavily 425 ANOVA, F 2,40 =42.01, p<0.0001). P60 +/mice also spent significantly less time asleep than 760 awake (P60 +/-Wake vs. P60 +/-Sleep: 2-way ANOVA, F 2,40 =42.01, p=0.002). In contrast, 761 P120 +/mice lacked any significant differences between durations of Wake and Sleep. 762
Between groups, time spent awake significantly decreased in P60 +/-(WT +/+ Wake vs. P60 +/-763 Wake: 2-way ANOVA, F 2,40 =42.01, p=0.009) and P120 +/mice (WT +/+ Wake vs. P120 +/-Wake: showed increased activity during the exploration and nesting phase. (C) P120 +/mice showed 797 significantly higher activity than WT +/+ and P60 +/mice (WT +/+ vs. P120 +/-: 1-Way ANOVA; 798 F 2,20 =20.18, p<0.001, P120 +/vs. P60 +/-: p<0.001). WT +/+ N=6 mice, P60 +/-N=6 mice, and 799 P120 +/-N=7 mice. (p<0.05 *, p<0.01 **; p<0.001 ***; post-hoc Bonferroni). the 40X image showed a significantly lower putative presynaptic puncta in the Het +/mice 841 (Nested t-test, t 37 =3.24, p=0.0026). PV+ puncta counts onto non-PV somas were also 842 significantly lower (Nested t-test, t 14 =2.398, p=0.03). PV+INs. CA3 Het +/-PV+INs had a significant increase in GluA2 expression (Nested t-test, 867
